Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT02945436 Completed - HIV Clinical Trials

Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention

Swerve
Start date: April 7, 2017
Phase: N/A
Study type: Interventional

A sample of 300 young (15-29) men who have sex with men (MSM) and transgender persons living in South-East Michigan's Detroit Metro Area (DMA) will be recruited through venue-based sampling and online ads to examine the efficacy of adding a substance use brief intervention (SUBI) to standard HIV prevention and care (SOC) for achieving gains in successful engagement in HIV care. The investigators will partner with Detroit-area AIDS Service Organizations (ASOs) to deliver the intervention.

NCT ID: NCT02945371 Completed - Smoking Clinical Trials

Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life

REV
Start date: September 2014
Phase: N/A
Study type: Interventional

Insufficient inhibitory control is one pathway through which early adversity is related to a range of problems including excessive alcohol use, tobacco use, and unhealthy eating. The proposed research leverages a neurally informed model of inhibitory control and how it can be improved to test the efficacy of a person-centered inhibitory control intervention in a sample of mid-life individuals with early adversity. The knowledge obtained by this study could be scaled into a flexible, low-cost, and wide-ranging intervention to remediate some of the effects of early adversity on inhibitory control and thus a number of prevalent health risking behaviors.

NCT ID: NCT02943408 Completed - Depression Clinical Trials

Development of a Patient Centered Mental Health Intervention for Recent Veterans

PCC MH
Start date: July 31, 2017
Phase: N/A
Study type: Interventional

Recent Veterans of the OIF/OEF/OND conflicts are presenting in VA care with high rates of: PTSD, depression, anxiety, and alcohol abuse, reporting significant difficulties with community reintegration, and dropping out of mental health care at high rates. Surveys of recent Veterans show that Veterans want the VA to provide mental health care tailored to their concerns and reintegration priorities. The VA is committed to providing personalized, proactive, patient centered care (PCC); but little research or intervention development has been done on PCC in mental health care settings and preliminary research indicates Veterans may lack the skills and knowledge to be active partners in PCC. This study aims to examine PCC behaviors in VA mental health care and, informed by this data, develop a brief patient centered mental health intervention that will help recent Veterans take the lead in their care personalization and support their functional recovery. Results from this study will demonstrate the acceptability, feasibility, and preliminary efficacy of this intervention.

NCT ID: NCT02942979 Completed - Mental Illness Clinical Trials

Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking

MISSION-HPACT
Start date: February 12, 2016
Phase:
Study type: Observational [Patient Registry]

This study seeks to implement wrap around services for Veterans suffering from co-occurring mental illness and substance use and who are homeless. It will compare Implementation as Usual of MISSION to Facilitation Implementation of MISSION.

NCT ID: NCT02939352 Completed - Alcoholism Clinical Trials

The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues

addictionTBS
Start date: September 2014
Phase: Early Phase 1
Study type: Interventional

High relapse rates among substance dependent individuals are likely due to a combination of factors that involve limbic circuits in the brain involved in craving, including vulnerability to salient cues. Emerging data suggests that non-invasive, targeted brain stimulation may be able to modulate activity in these circuits and decrease craving. The primary goal of this pilot study is to determine the extent to which a single session of continuous theta burst stimulation to the medial prefrontal cortex can attenuate limbic circuitry involved in craving among cocaine users and alcohol users. This will be tested through a double-blind,sham-controlled brain stimulation and brain imaging study in a cohort of polysubstance abusers and alcohol users.

NCT ID: NCT02930577 Completed - Clinical trials for Substance-Related Disorders

Treatment Adherence in Substance Users

TASU
Start date: October 2015
Phase: N/A
Study type: Observational

This study evaluates the factors associated with treatment adherence in substance users. Differences in the level of adherence to treatment according to patient-related factors, addiction and treatment are analyzed. The individual effect of each factor on treatment adherence is assessed.

NCT ID: NCT02926482 Completed - Opioid-use Disorder Clinical Trials

Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers

Start date: October 26, 2016
Phase: N/A
Study type: Interventional

This is a cluster-randomized controlled trial designed to increase the availability of buprenorphine and extended-release naltrexone treatment capacity for opioid use disorder (OUD). The intervention being tested is a bundle of OUD pharmacotherapy capacity building practices called the Prescriber Recruitment Bundle (PRB). For the study, 70 organizations will be identified and recruited, and those organizations will then be randomized into one of two arms: 1) control, and 2) intervention: organizations implementing the PRB using the Network for Improvement of Addiction Treatment (NIATx) Organizational Change Model. The primary research question is to test the impact of the PRB, relative to the control, on increasing buprenorphine treatment slots and extended-release naltrexone capacity and the number of patients receiving these pharmacotherapies.

NCT ID: NCT02923141 Completed - Clinical trials for Post Traumatic Stress Disorder

Trauma Intervention for Affect Regulation, AIDS, and Substances

TIARAS
Start date: January 2017
Phase: N/A
Study type: Interventional

The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.

NCT ID: NCT02922959 Completed - Clinical trials for Opioid-Related Disorders

A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses

TTIP-PRO
Start date: February 7, 2017
Phase: N/A
Study type: Interventional

This project will further develop and test the Tailored Telephone Intervention delivered by Peers to Prevent Recurring Opioid Overdoses (TTIP-PRO), a promising, low-cost, intervention to facilitate entry into medication assisted treatment (MAT) for individuals experiencing a non-fatal opioid overdoses (OOD). A prior small-scale pilot/feasibility study of TTIP-PRO (NCT02282306) found that the participating patients and the Peer Interventionists were satisfied with their participation, the intervention was acceptable, and the system for generating patient-tailored intervention information performed well. The overall goal of the present study is to conduct a pilot randomized controlled trial of TTIP-PRO versus a control group. It is hypothesized that patients in the TTIP-PRO group will have more favorable drug-abuse-related outcomes than patients in the control group.

NCT ID: NCT02911285 Completed - Clinical trials for Alcohol Use Disorder (AUD)

NAC for Treating Comorbid PTSD and SUD

DoD-NAC
Start date: October 2016
Phase: Phase 2
Study type: Interventional

As a result of sustained operations in Afghanistan and Iraq, there are an increasing number of U.S. military Veterans with substance use disorders and comorbid posttraumatic stress disorder (PTSD). If left untreated, individuals with substance use disorders and PTSD are at increased risk for developing other mental health problems (e.g., depression, anxiety), suicidal ideation and attempts, medical problems, reduced resiliency and military readiness, vocational problems, and family/social impairment. This study will determine the benefits of N-acetylcysteine (NAC) in treating alcohol use disorder and comorbid post-traumatic stress disorder (PTSD) among military Veterans.